Skip to main content
. 2020 Nov 28;2020:8834148. doi: 10.1155/2020/8834148

Table 2.

Overview of adverse events.

Adverse events All grades (%) Grade 1 (%) Grade 2 (%) Grade 3 (%) Grade 4 (%)
Hypertension 71 19 26 26 0
Decreased weight 70 30 33 7 0
Fatigue 59 33 26 0 0
Proteinuria 48 29 19 0 0
Diarrhea 44 26 9 7 2
Decreased appetite 23 14 9 0 0
Asthenia 21 19 2 0 0
Palmar-plantar erythrodysesthesia syndrome 14 12 0 2 0
Electrolyte derailment 14 12 2 0 0
Vomiting 7 7 0 0 0
QT-prolongation 5 5 0 0 0
Mouth dryness 5 5 0 0 0
Liver dysfunction 2 0 2 0 0